GlassScriptPhysician profile
Murray Freedman
NPI 1386747459
$48,462.36
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $428 · 2021: $27.42 · 2022: $15.79 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $46,665.26 | 2019-2020 | |
| Novo Nordisk INC | $562.58 | 2019-2024 | Wegovy |
| Amag Pharmaceuticals, INC. | $282.92 | 2019 | |
| Abbvie INC. | $181.15 | 2019-2022 | |
| Astellas Pharma US INC | $152.31 | 2019 | |
| Duchesnay USA Incorporated | $137.85 | 2019 | |
| Pfizer INC. | $111.54 | 2019-2020 | |
| Bausch Health US, LLC | $102.35 | 2019-2020 | |
| Vivus LLC | $53.99 | 2019-2020 | |
| Roche Diagnostics Corporation | $47.10 | 2019 | |
| Endo Pharmaceuticals INC. | $33.43 | 2020 | |
| Amgen INC. | $16.50 | 2019 | |
| Kvk-Tech, INC. | $14.47 | 2019 | |
| Millicent US INC | $14.37 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.58 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.71 | 2020 | |
| Currax Pharmaceuticals LLC | $12.67 | 2019 | |
| Daiichi Sankyo INC. | $12.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.23 | 2019 | |
| Allergan, INC. | $11.56 | 2020 | |
| Hologic Sales and Service, LLC | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Freedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.